51. Andrographolide Inhibits Corneal Fibroblast to Myofibroblast Differentiation In Vitro
- Author
-
Rozo, Vanessa, Quan, Melinda, Aung, Theint, Kang, Jennifer, Thomasy, Sara M, and Leonard, Brian C
- Subjects
Biomedical and Clinical Sciences ,Ophthalmology and Optometry ,Eye Disease and Disorders of Vision ,Prevention ,Wound Healing and Care ,Physical Injury - Accidents and Adverse Effects ,2.1 Biological and endogenous factors ,Eye ,Rabbits ,Rats ,Animals ,Transforming Growth Factor beta1 ,Myofibroblasts ,Actins ,Cells ,Cultured ,Fibroblasts ,Diterpenes ,Cornea ,Fibrosis ,RNA ,Messenger ,andrographolide ,corneal fibrosis ,corneal wound healing ,myofibroblast ,Biochemistry and Cell Biology ,Biochemistry and cell biology ,Bioinformatics and computational biology ,Medical biotechnology - Abstract
Corneal opacification due to fibrosis is a leading cause of blindness worldwide. Fibrosis occurs from many causes including trauma, photorefractive surgery, microbial keratitis (infection of the cornea), and chemical burns, yet there is a paucity of therapeutics to prevent or treat corneal fibrosis. This study aimed to determine if andrographolide, a labdane diterpenoid found in Andrographis paniculate, has anti-fibrotic properties. Furthermore, we evaluated if andrographolide could prevent the differentiation of fibroblasts to myofibroblasts in vitro, given that the transforming growth factor beta-1(TGF-β1) stimulated persistence of myofibroblasts in the cornea is a primary component of fibrosis. We demonstrated that andrographolide inhibited the upregulation of alpha smooth muscle actin (αSMA) mRNA and protein in rabbit corneal fibroblasts (RCFs), thus, demonstrating a reduction in the transdifferentiation of myofibroblasts. Immunofluorescent staining of TGF-β1-stimulated RCFs confirmed a dose-dependent decrease in αSMA expression when treated with andrographolide. Additionally, andrographolide was well tolerated in vivo and had no impact on corneal epithelialization in a rat debridement model. These data support future studies investigating the use of andrographolide as an anti-fibrotic in corneal wound healing.
- Published
- 2022